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SUMMARY
Objectives
Blood ketone (beta-hydroxybutyrate) measurements are suggested 
instead of urine ketone (acetoacetate) measurements in the diagnosis 
of diabetic ketoacidosis. Urine ketone examination is difficult and time 
consuming, and may result in an incorrect interpretation. Studies per-
formed in emergency departments on blood ketones are limited. Our 
objective is to compare urine ketones and capillary blood ketones in 
patients whose serum glucose levels were ≥150 mg/dl.
Methods
In our cross-sectional prospective study, finger-stick blood beta-hy-
droxybutyrate, arterial blood gas and urine ketone measurements of 
patients whose serum glucose levels were 150 mg/dL and higher were 
performed in the emergency department.
Results
A total of 265 patients were included in the study. The mean age of 
the patients was 62.4±14.9 years, and 65.7% of them were female. The 
mean of the capillary blood ketone levels of the patients was deter-
mined to be 0.524±0.9 mmol/L (min: 0 mmol/L, max: 6.7 mmol/L). In 
29 (13.1%) of the 221 patients whose urine ketone levels were nega-
tive, the finger-stick blood ketone levels were positive. Three of these 
patients were severely ketonemic, six were moderately ketonemic, and 
20 were mildly ketonemic.
Conclusions
In patients admitted to the emergency department with a blood glu-
cose level of 150 mg/dL or higher, performing a capillary blood ketone 
measurement instead of a urine ketone measurement was a better pre-
dictor of ketonemia.
Key words: Diabetic ketoacidosis; hydroxybutyrates; ketosis.
ÖZET
Amaç
Diyabetik keto asidoz tanısında idrar ketonu (asetoasetat) yerine kan 
ketonu (beta-hidroksibütirat) ölçümü önerilmektedir. İdrar ketonu 
bakılması zahmetli, zaman alıcı ve yanlış yorumlara yol açabilen bir 
testtir. Acil servislerde kan ketonu ile ilgili yapılan çalışmalar sınırlıdır. 
Bu çalışmadaki amacımız serum glikoz düzeyi ≥150 mg/dl tespit edilen 
hastalarda idrar ketonu ile kapiller kanda keton varlığını karşılaştır-
maktır.
Gereç ve Yöntem
İleriye yönelik kesitsel çalışmada, acil serviste serum glikoz düzeyi 150 
mg/dL ve üzerinde olan hastaların parmak ucu kan beta-hidroksibütirat, 
venöz kan gazı ve idrar ketonu ölçümü yapıldı.
Bulgular
Bu çalışmaya toplam 265 hasta dâhil edildi. Hastaların yaş ortalama-
sı 62.4±14.9 yıl, %65.7’si kadındı. İdrar ketonu negatif olan 221 hastanın 
29’unda (%13.1) parmak ucundan kan ketonu pozitif olarak saptandı. Bu 
hastaların üçü ağır, altısı orta düzeyli, 20’si hafif düzeyli ketonemikti. Ol-
guların kapiller kan keton düzeyleri ortalaması 0.524±0.9 mmol/L (min.: 0 
mmol/L, maks.: 6.7 mmol/L) tespit edildi.
Sonuç
Acil servise başvuran ve kan glikoz değeri 150 mg/dL üzerindeki hastalar 
içinde, idrar keton ölçümü yerine kapiller kan keton ölçümünün kullanıl-
ması hastaların yönetiminde önemli değişikliğe yol açabilir.
Anahtar sözcükler: Diyabetik ketoasidoz; hidroksibütirat; ketozis.
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Introduction
It has been reported that 25% of patients who are admitted 
to the emergency department (ED) are diabetic, and the rou-
tine glycemic control results of nearly half of these patients 
were negative. In emergency medicine practice, diabetic 
ketoacidosis (DKA) should be considered in patients whose 
blood glucose level is ≥250 mg/dL, regardless of symptoms.
[1] DKA is a severe complication of diabetes that is character-
ized by hyperglycemia, ketone body production and meta-
bolic acidosis.[2-4] Early diagnosis of DKA patients is critical 
because of the high mortality rate (2-5%).[5]
In current emergency medicine practice, ketonemia is fre-
quently tested using a urine dipstick that measures ace-
toacetate (AA) concentrations.[1] A urine dipstick does not 
measure the concentration of β-hydroxybutyrate (β-OHB), 
a major ketone body that plays an important role in DKA 
pathogenesis.[2-4]
Studies of blood ketone concentrations in ED patients are 
limited.[1,6-9] Detection of ketone bodies in capillary blood 
provides analytical, technical, and clinical advantages com-
pared to a urine dipstick test.[3] The objective of our study 
was to compare urine ketone (AA) and capillary blood ke-
tone (β-OHB) levels in ED patients whose serum glucose lev-
els were ≥150 mg/dl.
Materials and Methods 
Our cross-sectional prospective study was performed over 
a period of three months in the Department of Emergency 
Medicine of Izmir Tepecik Training and Research Hospital, 
a tertiary training clinic. Ethics committee approval was 
obtained before the study. All the patients included in the 
study gave consent.
Patient Selection
All the patients admitted to our ED who were older than 
14 years and whose serum glucose level was 150 mg/dL or 
higher were consecutively enrolled in the study. The criteria 
of the American Diabetes Association (ADA) were used for 
the definition of DKA as follows: blood glucose levels higher 
than 250 mg/dl, the existence of an anion gap greater than 
10, bicarbonate levels lower than 18 mEq/L, and 3 mmol/L 
ketonemia or significant ketonuria (“≥3+” by standard urine 
dipstick) with blood pH lower than 7.3.[1,4,10,11]
Patients who declined to participate in the study as well as 
any patients whose blood biochemical tests, blood gas anal-
ysis, or urine or capillary ketone measurements could not be 
performed for any reason were excluded from the study.
Study Protocol
Patients whose finger-stick blood glucose level was mea-
sured to be 150 mg/dL and higher for any reason were iden-
tified. Serum glucose levels, serum electrolyte (Na+1, K+1, 
Cl-1; to calculate the anion gap) measurements, complete 
urine tests, arterial blood gases (pH, lactate, HCO3-, base ex-
cess), and capillary blood ketone measurements were per-
formed.
Serum electrolytes and glucose levels were measured with 
an Olympus AU640 auto-analyzer. Arterial blood gas param-
eters were evaluated with a GEM Premier 3000 S/N 17839 
blood gas analyzer®. To avoid observer bias, complete urine 
tests were evaluated using DIRUI H10–800 urine dipsticks 
with a DIRUI H800 Urine Analyzer® device with a spectro-
photometric measurement technique. Urine ketone levels 
were grouped as no ketonemia, “trace quantity”, “1+”, “2+”, or 
“3+”.
Capillary blood glucose levels were measured with a Glu-
cometer® (HMD Biomedical Inc., Hsinchu, Taiwan) in mg/
dL at the bedside using a finger-stick test. Measurement of 
capillary blood ketone levels was performed at the bedside 
using β-ketone test strips (Optium-meter, Optium TM Xceed 
TM/Abbott®). Capillary blood ketone levels were grouped as 
follows: no ketonemia (0–0.5 mmol/L), mild ketonemia (0.6–
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Table 1. Comparison of capillary blood ketone levels with dipstick urine ketone levels 
Blood ketone Urine ketone levels Total
 – Trace 1+ 2+ 3+
 n % n % n % n % n % n %
No 192 72.4 18 6.8 1 0.4 0 0 0 0 211 79.6
Mild 20 7.5 7 2.6 5 1.9 0 0 2 0.8 34 12.8
Moderate 6 2.3 1 0.4 5 1.9 0 0 0 0 12 4.5
Severe 3 1.1 2 0.8 1 0.4 1 0.4 1 0.4 8 3
Total 221 83.4 28 10.6 12 4.5 1 0.4 3 1.1 265 100
levels
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1.5 mmol/L), moderate ketonemia (1.6–3.1 mmol/L) and 
severe ketonemia (3.2 mmol/L and higher). Patients whose 
blood ketone levels were determined to be higher than 0.5 
mmol/L were classified as “ketonemia positive“.
The socio-demographic (age, gender) and clinical properties 
(biochemical laboratory test results, finger-stick ketone lev-
els) required for the study were transferred from the patient 
medical records onto data collection forms for evaluation.
Statistical Analysis
Statistical analyses were performed using SPSS for Windows 
Ver. 17.0, (SPSS Inc., IL, USA). Non-parametric (qualitative) 
variables were shown as a number and percentage (%), and 
Mann-Whitney U and chi-square tests were used for evalu-
ation. In the crosstab values, when the expected value in at 
least one cell was less than five, Fisher’s Exact Test was used. 
Parametric (quantitative) data were shown as the mean 
± standard deviation (SD). For parametric data, analysis of 
variance (ANOVA), correlation, and regression analyses were 
used. In the statistical analysis, p<0.05 was accepted as sig-
nificant.
Results
The serum glucose levels of 408 patients who were admitted 
to ED in the course of our study were higher than 150 mg/
dl. A total of 143 patients were excluded from the study for 
the following reasons: 43 patients’ the urine ketones could 
not be studied; 56 patients’ blood gas analysis could not be 
studied; 27 patients’ blood biochemistry parameters could 
not be studied; and 17 patients refused to participate in the 
study. A total of 265 patients were included in the study, and 
174 (65.7%) of the patients were female. The mean age of 
the patients was 62.4±14.9 years (range: 15-96 years).
In 221 of the cases (83.4%), no ketones were found in the 
urine. In 29 (13.1%) of the patients who did not have ketonu-
ria, the capillary blood ketone (ketonemia) was determined 
to be positive (>0.5 mmol/L). Three (1.3%) of these patients 
were severely ketonemic, six (2.6%) were moderately keto-
nemic, and 20 (9.2%) were mildly ketonemic (Table 1). The 
mean capillary blood ketone level was determined to be 
0.524±0.9 mmol/L (range: 0-6.7 mmol/L). The relationship 
between the patients’ biochemical test results and capillary 
blood ketone levels is shown in Table 2. The comparisons of 
the capillary blood ketone levels and serum glucose, pH, lac-
tate and bicarbonate levels are shown in Table 3.
In 211 (79.6%) patients, no ketones were found in the cap-
illary blood. Twenty-nine (53.7%) of the 54 patients whose 
capillary blood ketone levels were positive had no ketonuria. 
Of these patients, 34 (12.8%) had mild ketonemia, 12 (4.1%) 
had moderate ketonemia, and 8 (3%) had severe ketonemia 
(Table 1).
Ten patients (3.8%) were identified who were positive for ke-
tonemia by capillary blood and who had a blood pH value 
of <7.3. Four (1.5%) of these patients were diagnosed as 
DKA according to the ADA criteria; one had a urine ketone 
level of “3+”, two had trace quantities, and one had a nega-
tive urine ketone test. These patients’ capillary blood ketone 
levels were determined as 6.7, 5.2, 3.5 and 6.3 mmol/L, re-
spectively.
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Table 2. Relationship between capillary ketone levels and laboratory results 
Ketone levels (mmol/L)
Variables All patients 0–0.5 0.6–1.5 1.6–3.1 ≥3.2 p
  (no) (mild) (moderate) (severe)
Capillary glucose (mg/dL) 282.1±107.4 273.3±98.6 279.6±118.6 362.1±144.6 404.7±114.7 =0.402
Serum glucose (mg/dL) 309.7±131.1 301.6±121.7 292.5±138.5 398.3±156.1 463.5±174 =0.878
Serum base excess -1.7±6.4 -1.1±5.4 -3.8±8.9 -1.6±5.7 -10.4±12.4 =0.001
Serum bicarbonate  (mmol/L) 22.8±5.5 23.7±4.7 20.7±6.2 22.5±4.8 10.2±5.5 =0.594
Serum pH 7.38±09 7.38±.1 7.37±.1 7.41±.1 7.32±0.1 =0.017
Anion gap 12.9±5.7 11.8±4.7 15.6±5.4 17.3±9.3 25.4±5.5 =0.011
Serum Lactate (mmol/L) 2.2±2.1 2.1±1.8 2.5±2.8 2.8±2.9 3.6±4.4 =0.064
Serum Sodium (Na+) (mEq/L) 136.2±5.9 136.5±5.2 136.1±7.8 133.6±10 133.9±8.9 =0.07
Serum Potassium (K+) (mEq/L) 4.4±0.7 4.5±.6 4.6±.8 4.1±.6 4.5±.8 =0.209
Serum Chlorine (Cl-) (mEq/L) 100.5±7.2 101.1±6 99.8±8.7 93.7±13.5 98.2±9.6 =0.01
Data are given as mean±standard deviation. p values are results of Fisher’s exact test.
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Although six patients’ pH values were <7.3, they were not 
considered to be DKA according to the ADA criteria, as three 
had blood glucose levels lower than 250 mg/dL; two had bi-
carbonate levels higher than 18 mmol/L; and one had capil-
lary blood ketone levels lower than 3 mmol/dL. Two of those 
patients had ketonuria (one patient had a trace quantity and 
the other “1+”), whereas no ketonuria was identified in the 
other four patients. All six patients had mild ketonemia (0.6, 
0.6, 1.2, 1.1, 0.9, 0.8 mmol/L, respectively).
Four (1.5%) patients who met the ADA DKA criteria except 
for having an arterial blood gas pH value greater than 7.3 
were considered to have compensated metabolic acidosis. 
The capillary blood ketone levels of these patients were 3.2, 
3.9, 5.6, and 5.2 mmol/L. No ketonuria was found in the urine 
tests of two of these patients, whereas one had “1+”, and the 
other had a trace quantity of ketonuria.
One hundred and eighty-one (68.3%) of the patients were 
discharged from the hospital. Four (1.5%) patients died, sev-
en (2.6%) refused treatment and fifteen (5.7%) were referred. 
Additionally, 17 (6.4%) patients were admitted to the inten-
sive care unit and 41 patients (15.5%) to other departments. 
Discussion
The main objective of our study was to compare blood ke-
tone levels with the presence of urine ketones in hyperglyce-
mic ED patients. We found that capillary ketone levels were 
high in 13% of the patients who had no ketonuria. Severe 
ketonemia was identified in 10% of these patients. In DKA, 
the β-OHB/AA ratio can increase from 1/1 to 5/1. With treat-
ment, β-OHB will be oxidized to AA. As a result, the measur-
able blood ketone levels (β-OHB) will decrease, whereas the 
measurable urine ketone levels (AA) will increase.[2] In our 
study, there were four patients who were diagnosed with 
DKA according to the ADA criteria. In spite of the fact that 
significant ketonemia was determined in these patients, the 
urine dipsticks only identified significant ketonuria (‘‘3+’’) in 
one of these patients. In the early stages of DKA, some cases 
might be missed if urine dipsticks for ketone detection are 
used instead of capillary blood ketone measurement.
It was determined that only four (1.5%) of the ten patients 
who had ketones in the capillary blood and whose pH value 
was <7.3 met the ADA DKA criteria. In our study, the capillary 
blood ketone levels of the four adults who were diagnosed 
with DKA were determined to be 3.5, 5.2, 6.3 and 6.7 mmol/L. 
Additionally, in six patients who did not meet the ADA cri-
teria, acidosis was determined with mild (0.6-1.5 mmol/L) 
ketonemia. Charles et al. reported a blood β-OHB threshold 
level of 3.5 mmol/L for the diagnosis of DKA,[8] whereas Sav-
age et al. reported this value to be ≥3 mmol/L.[11] Laffel et al. 
reported that all capillary blood ketone body values higher 
than 0.5 mmol/L are abnormal. In the populations that are 
a specific risk group for DKA (e.g. those who use insulin 
pumps), this value decreases to the lower limit value of 0.3 
Table 3. Comparison of capillary blood ketone levels and serum glucose, pH, lactate and bicarbonate levels 
Variable Ketone levels
 Ketosis (-) Ketosis (+)  
Serum glucose level 0–0.5 0.6–1.5 1.6–3.1 ≥3.2 Total p
(mg/dL) (No) (mild) (moderate) (severe)
  n % n % n % n % n %
150–249 92 34.7 17 6.4 1 0.4 0 0 110 41.5 =0.03
≥250 119 44.9 17 6.4 11 4.2 8 3 155 58.5
Acidosis      
 Yes (pH<7.3) 18 6.8 6 2.3 0 0 4 1.5 28 10.6 =0.001
 No (pH≥7.3) 193 72.8 28 10.6 12 4.5 4 1.5 237 89.4 
Bicarbonate level (mEq/L)      
 <18 11 4.2 6 2.3 1 0.4 6 2.3 24 9.1 <0.001
 ≥18 200 75.5 28 10.6 11 4.2 2 0.8 241 90.9 
Lactate level (mmol/L)      
 ≥4 197 74.3 28 10.6 11 4.2 6 2.3 242 91.3 =0.042
 <4 14 5.3 6 2.3 1 0.4 2 0.8 23 8.7 
p values are results of Fisher’s exact test.
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mmol/L.[12] Thus, although the aforementioned six patients 
are not considered as DKA according to ADA criteria, they 
might be diagnosed as being in the early stages of DKA. We 
hypothesize that, even at low levels, early stage DKA cases 
can be diagnosed with capillary blood ketone measure-
ment. Otherwise, these patients, whose blood ketone levels 
are less than 3 mmol/L, might be discharged from the hos-
pital without being adequately treated because they do not 
meet ADA criteria and are not diagnosed as DKA.
In current clinical practice, urine dipsticks are frequently used 
for ketone detection in patients presenting with hyperglyce-
mia in the ED. Urine dipsticks measure AA via a semi-quan-
titative method dependent on a sodium-nitroprusside reac-
tion. This test gives a weak reaction with acetone, whereas 
it has no reaction with β-OHB. When the spectrophotomet-
ric method is not used, the accuracy of the urine dipstick is 
user-dependent in the manner of sensing the color change 
on the dipstick.[2] The literature and the ADA encourage 
serum ketone measurement instead of urine dipstick tests 
because the specificity of urine dipsticks is low (<50%), and 
urine dipsticks frequently give false positive results, which 
cause an increased workload and inappropriate treatment.
[1-8,11,13-15] Umperriez et al. reported that, in more than half of 
patients, even after the ketoacidosis attack was eliminated, 
ketones were detected in the urine.[16] Urine dipstick tests 
can create an incorrect impression that ketosis has not been 
eliminated. The delay in urine sample collection in seriously 
dehydrated patients can cause delays in diagnosis. In anuric 
patients with end-stage renal failure, a urine dipstick cannot 
be used.[2] False negatives in urine ketone measurements 
might result from faulty urine dipsticks, urinary tract infec-
tions, and medications such as acetylcysteine, captopril and 
vitamin C.[1,3,6,8-10,13,14]
Blood ketones (β-OHB) can be measured in less than 30 
minutes with bedside finger-stick tests. Bedside finger-stick 
tests have several advantages over urine dipstick measure-
ments, including quick and quantitative results, ease of use, 
and repeatability in the ED.[1,3,6,8-10,13,14]
It has been reported that capillary ketone measurements are 
highly accurate, sensitive (98.1%) and specific (78.5%) for de-
tection of DKA.[1] Bektas et al. found the sensitivity and spec-
ificity of urine ketone dipstick testing and capillary blood 
ketone testing in determining DKA were 66% and 78%, and 
72% and 82%, respectively.[6]
In our study, the urine ketone level was determined to be 
negative in more than half of the patients whose capillary 
blood ketone level was positive. It should be considered 
that, in the management of hyperglycemic ED patients, 53% 
of the patients might be inappropriately treated if a urine 
dipstick is used. In cases in which the incidence and prog-
nosis of hyperglycemic patients admitted to the ED is based 
on an inappropriate diagnosis, the treatment administered 
might adversely affect the quality of patient care. Inad-
equate treatment could result in the re-admission of some 
patients to the ED. 
Limitations
Because pregnant women and children were not included 
in our study, our data must not be generalized to these pop-
ulations. We did not compare urine AA or capillary β-OHB 
ketone levels to serum β-OHB ketone levels, which is the 
gold standard in ketonemia diagnosis. There are studies re-
porting that the bedside capillary β-OHB ketone level test 
is as accurate and reliable as the serum β-OHB ketone level.
[1,6-10,13,14]
Conclusion
Capillary blood ketone measurement should be considered 
for use instead of urine ketone measurement in hyperglyce-
mic ED patients.
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